Am J Transplant, Volume 22, Suppl 3 Archives - Page 78 of 190 - ATC Abstracts

2022 American Transplant Congress
Abdominal Gynecologic Procedures Following Pancreas Transplantation: A Single Center Retrospective Analysis
E. Loya¹, J. A. Powelson¹, A. J. Lutz¹, K. Kasper², M. S. Richard¹, J. A. Fridell¹
¹Surgery, Indiana University School of Medicine, Indianapolis, IN, ²Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: The purpose of this study was to review the outcomes of abdominal gynecologic (gyne) procedures in patients who have previously undergone pancreas transplantation (PTx).*Methods:…
2022 American Transplant Congress
Recipient and Kidney Graft Outcomes of Human Immunodeficiency Virus Positive Deceased Donors in the United States
K. J. Swanson¹, R. El-Rifai¹, A. Bregman¹, R. Spong¹, V. Kirchner², T. Pruett², S. Jackson³, S. M. Riad¹
¹Division of Nephrology & Hypertension, University of Minnesota, Minneapolis, MN, ²Division of Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN, ³M-Health Fairview Analytics, Minneapolis, MN
*Purpose: With the inception of the HIV Organ Policy Act, HIV-positive donor to HIV-positive recipient kidney transplantation is a novel form of transplantation in the…
2022 American Transplant Congress
Impact of Kidney Transplant on Post-Operative Morbidity and Mortality in Patients with Pre-Existing Cardiac Conditions (Low Ejection Fraction): A Case Series
A. Kumar, C. Naso, D. Bacon, D. Gerber
Abdominal Transplant Surgery, UNC School of Medicine, Chapel Hill, NC
*Purpose: Patients with underlying cardiac diseases have higher morbidity and mortality as compared to the patients without any cardiac diseases. There has been a number…
2022 American Transplant Congress
The Feasibility of Changing HCC MELD Exception Criteria to an Exclusive DCD-Only Option: A Strategy to Increase DCD Utilization
G. J. McKenna, P. Schultz, M. Finotti, M. Rosenzweig, A. Gupta, S. H. Lee, A. Wall, E. Martinez, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: Outcomes of DCD liver transplantation is comparable to DBD but routine utilization of DCD liver grafts is surprisingly uneven in the US. A more…
2022 American Transplant Congress
The High Incidence of Long-COVID-19 in Kidney Transplant Recipients: A Longitudinal Cohort Study
V. Lafico Teixeira Gomes, P. Quintino, H. Tedesco, J. Medina, C. Eduardo Neves Amorim, M. Cristelli
Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil
*Purpose: This study aimed to investigate the clinical consequences at 3 months after symptom onset among kidney transplant recipients surviving COVID-19.*Methods: This is an ongoing…
2022 American Transplant Congress
Beyond CPRA: Identifying Sensitized Kidney Candidates with Markedly Low Access to Transplant
K. Bradbrook¹, A. Maldonado², K. Sjöholm², C. Kjellman², J. Lee³, D. Stewart¹
¹UNOS, Richmond, VA, ²Hansa Biopharma AB, Lund, Sweden, ³Immucor, Norcross, GA
*Purpose: The Kidney Allocation System (KAS) improved the rates of transplantation in highly sensitized (HS) patients. However, a subset of HS patients remain at a…
2022 American Transplant Congress
Natural vs Induced ABO Antibodies in a Murine Model: Role of Sex and T Cells
I. Adam¹, B. Motyka¹, K. Tao¹, P. J. Cowan², L. J. West¹
¹University of Alberta, Edmonton, AB, Canada, ²University of Melbourne, Melbourne, Australia
*Purpose: Interaction of ‘natural’ ABO antibodies (nAbs) with their cognate AB(H)-antigens (Ags) poses a high risk of rapid rejection of ABO-incompatible (ABOi) organ transplants. We…
2022 American Transplant Congress
Generation Of Insulin Producing Cells From Pancreatic Tissue With Long Standing Type 1 Diabetes
Y. Garciafigueroa, J. B. Pollett, N. L. Thai, R. Bottino
Imagine Pharma, Pittsburgh, PA
*Purpose: AIPCs (Activated Islet Proliferating Cells), are a novel cell population from isolated human islets obtained using a simple culture protocol that can generate cells…
2022 American Transplant Congress
Belatacept Conversion in Proteinuric Kidney Transplant Recipients: Effects in a Prospective Trial and a Retrospective Cohort
O. Efe¹, A. Al Jurdi¹, D. Wojciechowski², K. Safa¹, H. Gilligan¹, A. Chandraker³, J. Azzi³, A. Weins³, L. V. Riella¹
¹Center for Transplantation Sciences, Massachusetts General Hospital, Charlestown, MA, ²UT Southwestern Medical Center, Dallas, TX, ³Brigham and Women's Hospital, Boston, MA
*Purpose: Proteinuria after kidney transplantation is associated with worse allograft outcomes. B7-1 expression by podocytes has been linked to proteinuria by inducing podocyte migration which…
2022 American Transplant Congress
Sex Disparities in Access to Liver Transplant for Waitlisted Patients with Meld 40
D. C. Cron¹, H. Yeh¹, H. J. Braun², N. L. Ascher², D. C. Chang¹, J. T. Adler³
¹Surgery, Massachusetts General Hospital, Boston, MA, ²Surgery, University of California San Francisco, San Francisco, CA, ³Surgery and Perioperative Care, University of Texas at Austin, Austin, TX
*Purpose: Women with end-stage liver disease are less likely than men to receive a liver transplant, due in part to MELD’s reliance on creatinine and…